RDiscovery

Brings more than 20 years of experience in search and evaluation, business development, and venture investment; previously VP of Corporate Development at Ora and spent over 13 years at Daiichi-Sankyo. Holds degrees from Tokyo Univ. of Agriculture and Technology, San Diego State, and an MBA from UCSD.

Has over 20 years of experience in drug discovery, licensing, and search and evaluation; previously at Nippon Boehringer Ingelheim. Holds an MSc from Kyoto University and a PhD from Nagoya City University.

Has over 20 years of business development and venture investment experience, engaged in technology sourcing, company creation, and serving as director for portfolio companies; previously held board and management roles at Mitsui. Holds a BS in Engineering from the University of Tokyo.

A venture partner and serial entrepreneur with over 25 years in corporate development; co-founded and was CBO of Vincerx and served as President of Digestome Therapeutics. Holds a Biology BA from UC Santa Cruz and a PhD in Endocrinology from UC Berkeley.

Has 16 years of experience in DDS technology for nucleic acid drugs at a bio-venture, spanning basic research through clinical trials with a focus on pharmacodynamics.

An internationally known stem cell expert and serial entrepreneur who has founded five biotechnology companies and led numerous clinical trials; previously professor at UC Irvine and co-founder of the Sue and Bill Gross Stem Cell Research Center.

Chief Medical Officer at RDiscovery with over 30 years of clinical, research, and pharmaceutical industry experience, including 18 years at Pfizer, Merck, and Bristol Myers Squibb. Holds an MD and PhD from Jichi Medical University, an MBA, and an MPH from Johns Hopkins.

Has about 10 years of applied biotech research at a major electronics manufacturer and over 8 years at drug discovery ventures; joined RDiscovery in 2021. Holds a PhD from Ochanomizu University.

Has over 18 years of business experience in drug discovery, patent practice, and technology transfer, previously at Tohoku Techno Arch. Holds an MSc from Tohoku University and an MBA from GLOBIS University.

Has 7 years of experience in drug discovery at NapaJen Pharma as a lab manager focusing on in vitro pharmacological studies; engaged in drug discovery research for RDiscovery since 2021.

A physician-scientist specializing in transplantation immunology and regenerative medicine, professor at Kyoto Prefectural University of Medicine, and founder of IMEL Biotherapeutics; became Scientific Advisor to RDiscovery in 2023.

A pharmaceutical scientist with a PhD from Osaka University and research experience in molecular biology and immunology at UCLA, University of Toronto, and RIKEN; has worked on open innovation at Bayer, AbbVie, and Boehringer Ingelheim and moved to Kyoto University in 2019.

Has over 28 years of experience in business development, healthcare consulting, and venture investment, including 12 years with Mitsui Ventures; previously at Cambridge Pharma Consultancy, Genzyme Japan, and SRL. Holds an AB from Harvard and MBA from Cornell.